$26.33
▲ +2.0% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
MD: Raising target price to $27.00
Is Pediatrix Medical Group (MD) Overvalued As It Reaffirms Its 2026 EBITDA Outlook?
Stable Payor Mix And Reaffirmed Outlook Might Change The Case For Investing In Pediatrix (MD)
Overview
52-week range
$12
$25
100% of range
Avg surprise (last 3)
+27.6%
Avg reaction (last 2)
+2.4%
50% positive
Latest IV / EM
70%
EM ±16.0% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.41 | $0.34 | +20.6% | +32.3% | -7.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.84 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.51 | $0.40 | +27.5% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.31 | $0.23 | +34.8% | — | +11.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.23 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.84 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.05 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.26 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.34 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | BMO | $0.54 | $0.51 | +5.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $476M | — | $493M | $469M | $458M | — | $511M | $504M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $42M | — | $68M | $60M | $32M | — | $34M | $-158M |
| Net income | $30M | — | $72M | $39M | $21M | — | $19M | $-153M |
| EPS (diluted) | $0.36 | — | $0.84 | $0.46 | $0.24 | — | $0.23 | $-1.84 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $206M | $375M | $340M | $225M | $99M | $230M | $104M | $19M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $587M | $764M | $717M | $613M | $492M | $640M | $528M | $429M |
| Total assets | $2.07B | $2.25B | $2.20B | $2.10B | $1.99B | $2.15B | $2.08B | $2.00B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.19B | $1.38B | $1.31B | $1.27B | $1.20B | $1.39B | $1.34B | $1.29B |
| Total equity | $879M | $866M | $891M | $834M | $789M | $765M | $732M | $706M |